Types of Ehlers-Danlos Syndromes (EDS)

There are many types of Ehlers-Danlos syndromes (EDS).

What is Ehlers Danlos Syndrome?

Based on the inheritance pattern, EDS can be classified as autosomal dominant, autosomal recessive, and autosomal dominant or recessive. In each of these types, a set of major and minor criteria is identified and a minimal criterion is arrived at for the physicians to suggest the EDS types. Molecular testing is typically used to confirm the final diagnosis.

Autosomal dominant EDS

Below are the types of EDS that develop due to an autosomal dominant inheritance pattern:

  • Classical
  • Vascular
  • Hypermobile
  • Arthrochalasia
  • Periodontal

The two major criteria for Classical EDS (cEDS) include atrophic scarring and hyperextensibility of the skin, as well as generalized joint hypermobility (GJH). When these two major criteria, or the first major criterion in combination with a minimum of three minor criteria (out of 9 minor criteria), is present, cEDS is suggested as the appropriate diagnosis.

The heterozygous mutation of the gene COL3A1 causes Vascular EDS (vEDS). Testing is considered when there is a family history of the disorder. Additionally, the presence of a few major criteria, out of the 5, combined with few other minor criteria, out of 12, will confirm the presence of vEDS.

There is no sufficient data established as criteria to diagnose Hypermobile EDS (hEDS), whereas three major and five minor criteria are established for Arthrochalasia EDS (aEDS). Diagnosis is suggested when major criteria 1 & 3 are present, or when major criterion 2 combines with a minimum of two minor criteria.

When the C1R gene is absent or a C1S gene mutations exists, Periodontal EDS (pEDS) is likely the appropriate diagnosis.

EDS: An Invisible Illness

Autosomal recessive

Autosomal recessive inheritance results in the following types of EDS:

  • Classical-like
  • Cardiac-valvular
  • Dermatosparaxis
  • Kyphoscoliotic
  • Brittle Cornea Syndrome
  • Spondylodysplastic
  • Musculocontractural

Classical-like EDS (clEDS) is caused by the absence of Tenascin XB, which is the only gene related with clEDS. Although seven minor criteria are identified, physicians will only suggest clEDS when all three major criteria are present, along with an autosomal recessive inheritance family history.

Cardiac-valvular EDS (cvEDS) is caused by biallelic mutations of the gene COL1A2, which is the only gene related to cvEDS. The diagnosis for this type of EDS occurs when there is a family history of autosomal recessive type combined with the first major criterion and either one other major criterion or a minimum of two minor criteria.

With 9 major and 11 minor criteria defined, Dermatosparaxis EDS (dEDS) is suggested when there is extreme fragility of the skin and distinctive craniofacial features. These are two major criteria that must be present for a dEDS diagnosis, along with either one major criterion or three minor criteria. The only gene connected with dEDS is ADAMTS2 and its biallelic mutations result in dEDS.

Kyphoscoliotic EDS (kEDS) is suggested when the first two major criteria are present, along with either the third major criteria or three general or gene-related criteria. Mutations of the genes PLOD1 or FKBP14 result in kEDS.

Brittle Cornea Syndrome (BCS) is due to the biallelic mutations of either ZNF469 gene or PRDM5 gene. Diagnosis is recommended when the first major criteria of a thin cornea with a thickness of central corneal less than 400 µm without rupture or sometimes ruptured is present along with one more major criteria. The major criteria that can support a BCS diagnosis include an early start of keratoconus, the early beginning of keratoglobus that are progressive, and blue sclera. A diagnosis of BCS can also be achieved when first major criterion combines with any 3 of the 14 minor criteria.

For Spondylodysplastic EDS (spEDS), three major, five minor, and specific criteria related to genes B4GALT7, B3GALT6, and SLC39A13 are identified. Diagnosis is suggested when the first two major criteria, distinctive radiographic abnormalities, are present in combination with a minimum of three minor criteria that are either general or specific to the gene.

Biallelic mutations of the gene CHST14 are responsible for Musculocontractural EDS (mcEDS). Though 15 minor criteria are defined, suggestion for this type of EDS is based on the identified three major criteria. When the first two major criteria are present in the individual at birth, during early childhood, or when the first and third major criteria are present in adolescents and adults, mcEDS is suggested.

Autosomal dominant or recessive

Myopathic EDS (mEDS) is either autosomal dominant or recessive. Biallelic mutations of the gene COL12A1 are the cause of this type of EDS, in which Type XII Collagen protein is involved. With three major and four minor criteria defined, physicians suggest a diagnosis if the first major criterion is present with either one other major criterion or three minor criteria.

EDS Groups

Based on the similarities of the EDS causing genes affecting the human body, EDS can also be grouped as:

Group

Disorder/defects in

EDS types

Group A

Primary structure of collagen and processing of collagen

cEDS

vEDS

aEDS

dEDS

cvEDS

Group B

Folding and crosslinking of collagen

kEDS-PLOD1

kEDSS-FKB14

Group C

Structure and role of the myomatrix

ClEDS

mEDS

Group D

Biosynthesis of glycosaminoglycan

spEDS-B4GALT7

spEDS-b3GALT6

mcEDS-CHST14

mcEDS-DSE

Group E

Complement pathway

pEDS

Group F

Intracellular processes

spEDS-SLC39A13

BCS

Group G

Form of EDS that is not resolved

hEDS

References

Further Reading

Last Updated: Apr 7, 2023

Afsaneh Khetrapal

Written by

Afsaneh Khetrapal

Afsaneh graduated from Warwick University with a First class honours degree in Biomedical science. During her time here her love for neuroscience and scientific journalism only grew and have now steered her into a career with the journal, Scientific Reports under Springer Nature. Of course, she isn’t always immersed in all things science and literary; her free time involves a lot of oil painting and beach-side walks too.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Khetrapal, Afsaneh. (2023, April 07). Types of Ehlers-Danlos Syndromes (EDS). News-Medical. Retrieved on November 21, 2024 from https://www.news-medical.net/health/Types-of-Ehlers-Danlos-Syndromes-(EDS).aspx.

  • MLA

    Khetrapal, Afsaneh. "Types of Ehlers-Danlos Syndromes (EDS)". News-Medical. 21 November 2024. <https://www.news-medical.net/health/Types-of-Ehlers-Danlos-Syndromes-(EDS).aspx>.

  • Chicago

    Khetrapal, Afsaneh. "Types of Ehlers-Danlos Syndromes (EDS)". News-Medical. https://www.news-medical.net/health/Types-of-Ehlers-Danlos-Syndromes-(EDS).aspx. (accessed November 21, 2024).

  • Harvard

    Khetrapal, Afsaneh. 2023. Types of Ehlers-Danlos Syndromes (EDS). News-Medical, viewed 21 November 2024, https://www.news-medical.net/health/Types-of-Ehlers-Danlos-Syndromes-(EDS).aspx.

Comments

  1. Laura Wrede Laura Wrede United States says:

    "There is no sufficient data established as criteria to diagnose Hypermobile EDS (hEDS)".

    I don't believe that this is a correct statement. There is currently no gene identified for hEDS, however, there are definitely criteria set to diagnose hEDS.

    Please refer to the new guidelines for Ehlers Danlos Syndrome from the 2017 EDS International Consortium published in the American Journal of Medical Genetics Part C: Seminars in Medical Genetics. Many other updated references can be found here: ehlers-danlos.com/.../

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.